tradingkey.logo

Bioventus Inc

BVS
7.460USD
+0.080+1.08%
收盤 12/26, 16:00美東報價延遲15分鐘
499.62M總市值
47.61本益比TTM

Bioventus Inc

7.460
+0.080+1.08%

關於 Bioventus Inc 公司

Bioventus Inc. is a medical device company. The Company’s portfolio of products is grouped into three areas. Its Pain Treatments include the Knee Osteoarthritis (KOA) area, and Peripheral Nerve Stimulation (PNS) area. Its Surgical Solutions include Ultrasonics, which offers precision bone resection for patients with degenerative spine conditions and spinal deformities, and Bone Graft Substitutes (BGS), which includes a range of products that facilitate optimal bone fusion following a surgical procedure. Its Restorative Therapies comprise Fracture Care that provide low-intensity pulse ultrasound to help patients who suffer from bone fractures that do not heal through traditional methods. It offers a diverse portfolio of products to support physicians in relieving pain and addressing musculoskeletal challenges across indications and clinical areas, including knee, hand and upper extremities, foot and ankle, podiatry, trauma, general surgery, spine and neurosurgery.

Bioventus Inc簡介

公司代碼BVS
公司名稱Bioventus Inc
上市日期Feb 11, 2021
CEOClaypoole (Robert E)
員工數量930
證券類型Ordinary Share
年結日Feb 11
公司地址4721 Emperor Boulevard, Suite 100
城市DURHAM
上市交易所NASDAQ OMX - NASDAQ BASIC
國家United States of America
郵編27703
電話19194746700
網址https://www.bioventus.com/
公司代碼BVS
上市日期Feb 11, 2021
CEOClaypoole (Robert E)

Bioventus Inc公司高管

名稱
名稱/職務
職務
持股
持股變動
Mr. Anthony D'adamio, J.D.
Mr. Anthony D'adamio, J.D.
Senior Vice President, General Counsel
Senior Vice President, General Counsel
134.37K
+7.98%
Ms. Susan M. Stalnecker
Ms. Susan M. Stalnecker
Independent Director
Independent Director
105.96K
+33.34%
Mr. Guy Paul Nohra
Mr. Guy Paul Nohra
Independent Director
Independent Director
100.12K
--
Mr. Guido J. Neels
Mr. Guido J. Neels
Independent Director
Independent Director
85.24K
+45.10%
Mr. John A. Bartholdson
Mr. John A. Bartholdson
Independent Director
Independent Director
79.62K
+74.79%
Mr. Patrick J. (Pat) Beyer
Mr. Patrick J. (Pat) Beyer
Independent Director
Independent Director
76.44K
+53.05%
Ms. Michelle Mcmurry-Heath, M.D., Ph.D.
Ms. Michelle Mcmurry-Heath, M.D., Ph.D.
Independent Director
Independent Director
57.00K
-23.70%
Mr. Philip G. Cowdy
Mr. Philip G. Cowdy
Independent Director
Independent Director
11.70K
--
Mr. Mark Singleton
Mr. Mark Singleton
Chief Financial Officer, Senior Vice President
Chief Financial Officer, Senior Vice President
--
--
Ms. Katrina Church, J.D.
Ms. Katrina Church, J.D.
Senior Vice President, Chief Compliance Officer
Senior Vice President, Chief Compliance Officer
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Mr. Anthony D'adamio, J.D.
Mr. Anthony D'adamio, J.D.
Senior Vice President, General Counsel
Senior Vice President, General Counsel
134.37K
+7.98%
Ms. Susan M. Stalnecker
Ms. Susan M. Stalnecker
Independent Director
Independent Director
105.96K
+33.34%
Mr. Guy Paul Nohra
Mr. Guy Paul Nohra
Independent Director
Independent Director
100.12K
--
Mr. Guido J. Neels
Mr. Guido J. Neels
Independent Director
Independent Director
85.24K
+45.10%
Mr. John A. Bartholdson
Mr. John A. Bartholdson
Independent Director
Independent Director
79.62K
+74.79%
Mr. Patrick J. (Pat) Beyer
Mr. Patrick J. (Pat) Beyer
Independent Director
Independent Director
76.44K
+53.05%

收入明細

單位: USD更新時間: 10月6日 週一
單位: USD更新時間: 10月6日 週一
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
業務USD
名稱
營收
佔比
Pain Treatments and Joint Preservation
73.31M
49.65%
Surgical solutions
52.72M
35.70%
Restorative Therapies
21.64M
14.65%
地區USD
名稱
營收
佔比
United States
128.78M
87.21%
International
18.89M
12.79%
業務
地區
業務USD
名稱
營收
佔比
Pain Treatments and Joint Preservation
73.31M
49.65%
Surgical solutions
52.72M
35.70%
Restorative Therapies
21.64M
14.65%

股東統計

更新時間: 11月17日 週一
更新時間: 11月17日 週一
持股股東
股東類型
持股股東
持股股東
佔比
EW Healthcare Partners
19.44%
Juniper Investment Company, LLC
10.36%
Smith & Nephew Group plc
9.30%
Nantahala Capital Management, LLC
8.68%
The Vanguard Group, Inc.
4.30%
其他
47.92%
持股股東
持股股東
佔比
EW Healthcare Partners
19.44%
Juniper Investment Company, LLC
10.36%
Smith & Nephew Group plc
9.30%
Nantahala Capital Management, LLC
8.68%
The Vanguard Group, Inc.
4.30%
其他
47.92%
股東類型
持股股東
佔比
Investment Advisor/Hedge Fund
22.94%
Venture Capital
19.55%
Investment Advisor
15.40%
Hedge Fund
14.00%
Corporation
9.30%
Individual Investor
2.50%
Research Firm
1.72%
Insurance Company
0.47%
Bank and Trust
0.20%
其他
13.93%

機構持股

更新時間: 12月8日 週一
更新時間: 12月8日 週一
報告期間
機構數
持股數
持股佔比
持股變動
2025Q4
319
49.87M
91.76%
-1.55K
2025Q3
324
49.87M
92.42%
+451.64K
2025Q2
315
49.43M
88.24%
+1.39M
2025Q1
300
47.59M
85.68%
-9.15M
2024Q4
302
46.29M
87.45%
+580.76K
2024Q3
303
45.64M
84.02%
-1.26M
2024Q2
271
47.35M
78.83%
+4.38M
2024Q1
269
42.96M
79.86%
-7.88M
2023Q4
267
41.98M
81.20%
+236.50K
2023Q3
256
41.69M
80.71%
+844.38K
查看更多

股東持股明細

名稱
持股數
佔比
持股變動
變動比例
公告日期
EW Healthcare Partners
13.02M
19.47%
--
--
Jun 30, 2025
Juniper Investment Company, LLC
6.94M
10.37%
--
--
Jun 30, 2025
Smith & Nephew Group plc
6.23M
9.31%
--
--
Apr 07, 2025
Nantahala Capital Management, LLC
5.28M
7.89%
+1.16M
+28.00%
Jun 30, 2025
The Vanguard Group, Inc.
2.77M
4.14%
+223.28K
+8.77%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
2.82M
4.21%
+259.59K
+10.15%
Jun 30, 2025
Royce Investment Partners
1.09M
1.63%
+199.86K
+22.40%
Jun 30, 2025
Geode Capital Management, L.L.C.
1.05M
1.58%
+122.14K
+13.09%
Jun 30, 2025
American Century Investment Management, Inc.
1.12M
1.68%
+79.83K
+7.64%
Jun 30, 2025
Kent Lake PR LLC
350.04K
0.52%
+350.04K
--
Jun 30, 2025
查看更多

持股ETF

更新時間: 12月6日 週六
更新時間: 12月6日 週六
機構名稱
佔比
Vanguard US Multifactor ETF
0.1%
VictoryShares Small Cap Free Cash Flow ETF
0.1%
Harbor Human Capital Factor US Small Cap ETF
0.09%
Fidelity Enhanced Small Cap ETF
0.09%
iShares Micro-Cap ETF
0.06%
Principal U.S. Small-Cap ETF
0.05%
Vanguard US Value Factor ETF
0.04%
Humankind US Stock ETF
0.03%
WisdomTree US SmallCap Fund
0.03%
Avantis US Small Cap Value ETF
0.03%
查看更多
Vanguard US Multifactor ETF
佔比0.1%
VictoryShares Small Cap Free Cash Flow ETF
佔比0.1%
Harbor Human Capital Factor US Small Cap ETF
佔比0.09%
Fidelity Enhanced Small Cap ETF
佔比0.09%
iShares Micro-Cap ETF
佔比0.06%
Principal U.S. Small-Cap ETF
佔比0.05%
Vanguard US Value Factor ETF
佔比0.04%
Humankind US Stock ETF
佔比0.03%
WisdomTree US SmallCap Fund
佔比0.03%
Avantis US Small Cap Value ETF
佔比0.03%

分紅派息

近5年累計派現 0.00 美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據

拆合股

公告日期
類型
比率
暫無數據
公告日期
類型
比率
暫無數據

常見問題

Bioventus Inc的前五大股東是誰?

Bioventus Inc的前五大股東如下:
EW Healthcare Partners
持有股份:13.02M
佔總股份比例:19.47%。
Juniper Investment Company, LLC
持有股份:6.94M
佔總股份比例:10.37%。
Smith & Nephew Group plc
持有股份:6.23M
佔總股份比例:9.31%。
Nantahala Capital Management, LLC
持有股份:5.28M
佔總股份比例:7.89%。
The Vanguard Group, Inc.
持有股份:2.77M
佔總股份比例:4.14%。

Bioventus Inc的前三大股東類型是什麼?

Bioventus Inc 的前三大股東類型分別是:
EW Healthcare Partners
Juniper Investment Company, LLC
Smith & Nephew Group plc

有多少機構持有Bioventus Inc(BVS)的股份?

截至2025Q4,共有319家機構持有Bioventus Inc的股份,合計持有的股份價值約為49.87M,占公司總股份的91.76% 。與2025Q3相比,機構持股有所增加,增幅為-0.66%。

哪個業務部門對Bioventus Inc的收入貢獻最大?

在FY2025Q2,Pain Treatments and Joint Preservation業務部門對Bioventus Inc的收入貢獻最大,創收73.31M,占總收入的49.65% 。
KeyAI